Novel Oral Anticoagulant versus Warfarin in Cancer Patients with Atrial Fibrillation: An 8-Year Population-Based Cohort Study

Background: Cancer patients with atrial fibrillation (AF) were excluded in the major clinical trials. We therefore investigated the efficacy and safety of novel oral anticoagulant (NOAC) versus warfarin in these patients. Methods: Data were retrieved from Taiwan National Health Insurance Research Da...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cancer
Auteurs principaux: Wu, Victor Chien-Chia, Wang, Chun-Li, Huang, Yu-Tung, Lan, Wen-Ching, Wu, Michael, Kuo, Chang-Fu, Chen, Shao-Wei, Chu, Pao-Hsien, Wen, Ming-Shien, Kuo, Chi-Ching, Chang, Shang-Hung
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2020
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930400/
https://ncbi.nlm.nih.gov/pubmed/31892976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.36468
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires